These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15794860)

  • 21. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance.
    Blade J; Lopez-Guillermo A; Rozman C; Cervantes F; Salgado C; Aguilar JL; Vives-Corrons JL; Montserrat E
    Br J Haematol; 1992 Jul; 81(3):391-4. PubMed ID: 1390212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemia.
    Kyle RA; Therneau TM; Dispenzieri A; Kumar S; Benson JT; Larson DR; Melton LJ; Rajkumar SV
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):184-6. PubMed ID: 23490989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands.
    van de Poel MH; Coebergh JW; Hillen HF
    Br J Haematol; 1995 Sep; 91(1):121-5. PubMed ID: 7577618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
    Morra E; Cesana C; Klersy C; Barbarano L; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Miqueleiz S; Bernuzzi P; Nosari AM; Lazzarino M
    Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
    Pasqualetti P; Casale R
    Biomed Pharmacother; 1997; 51(2):74-8. PubMed ID: 9161471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological correlates of IgM paraproteinemias.
    Owen RG; Parapia LA; Higginson J; Misbah SA; Child JA; Morgan GJ; Jack AS
    Clin Lymphoma; 2000 Jun; 1(1):39-43; discussion 44-5. PubMed ID: 11707811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal gammopathies of undetermined significance: a review.
    Kyle RA; Rajkumar SV
    Immunol Rev; 2003 Aug; 194():112-39. PubMed ID: 12846812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiology of monoclonal gammopathy in a general hospital and a university internal medicine department].
    Decaux O; Rodon P; Ruelland A; Estepa L; Leblay R; Grosbois B
    Rev Med Interne; 2007 Oct; 28(10):670-6. PubMed ID: 17566610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Malignant transformation of monoclonal gammopathy of undetermined significance].
    Decaux O; Avet-Loiseau H; Grosbois B
    Presse Med; 2007 Dec; 36(12 Pt 3):1985-96. PubMed ID: 17509811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
    Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders.
    Pangalis GA; Kyrtsonis MC; Kontopidou FN; Siakantaris MP; Dimopoulou MN; Vassilakopoulos TP; Tzenou T; Kokoris S; Dimitriadou E; Kalpadakis C; Tsalimalma K; Tsaftaridis P; Panayiotidis P; Angelopoulou MK
    Clin Lymphoma; 2005 Mar; 5(4):235-40. PubMed ID: 15794855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
    Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal gammopathy of undetermined significance.
    Kyle RA
    Blood Rev; 1994 Sep; 8(3):135-41. PubMed ID: 7819815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal gammopathy of undetermined significance (MGUS)-31 year follow up of a community study.
    Colls BM
    Aust N Z J Med; 1999 Aug; 29(4):500-4. PubMed ID: 10868527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors predicting transformation of asymptomatic IgM monoclonal gammopathy.
    Greco A; Tedeschi A; Varettoni M; Nichelatti M; Paris L; Ricci F; Vismara E; Morra E
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):77-9. PubMed ID: 21454196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The natural history of monoclonal gammopathy of undetermined significance. A 5- to 20-year follow-up of 263 cases.
    Pasqualetti P; Festuccia V; Collacciani A; Casale R
    Acta Haematol; 1997; 97(3):174-9. PubMed ID: 9066713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).
    Kvarnstrom M; Sidorova E; Nilsson J; Ekerfelt C; Vrethem M; Soderberg O; Johansson M; Rosen A; Ernerudh J
    Clin Exp Immunol; 2002 Feb; 127(2):255-62. PubMed ID: 11876747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
    Go RS; Gundrum JD; Neuner JM
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymptomatic Waldenstrom's macroglobulinemia.
    Alexanian R; Weber D; Delasalle K; Cabanillas F; Dimopoulos M
    Semin Oncol; 2003 Apr; 30(2):206-10. PubMed ID: 12720137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.